Sartorius Stedim Biotech S.A. ranks below the peer group median, with a relatively even profile across the main dimensions. The market setup has weakened, with clear trend damage and relative performance under pressure.
Peer-relative scores, weakest to strongest
Sartorius Stedim Biotech S.A. supplies bioprocessing equipment and consumables to the biopharmaceutical industry.
The market prices Sartorius Stedim Biotech on deteriorating margin and efficiency trends, not on sustained quality leadership. With an EBITDA margin of 31.2% for FY25, now below previous peaks, and a ROIC of 7.8% that is below the sector median, the market consistently applies a valuation discount, treating Sartorius Stedim Biotech as a laggard on quality metrics rather than rewarding it as a growth anchor. Because Sartorius Stedim Biotech’s operating margin and return on capital have declined over multiple years, the stock remains priced below former valuation levels. In bioprocessing, margin stability and capital returns are the core quality anchors, so the current pricing reflects Sartorius’s step back versus sector peers. Only a return of EBITDA margins to former highs and a clear turnaround in capital returns would change the market’s current assessment.
Break down DIM.PA's position across all dimensions with the full interactive tool.
This analysis is rule-based and descriptive. Peer-relative scores are derived from functional peer group comparisons using publicly available financial data. Scores reflect structural positioning only and do not constitute investment advice, a buy or sell recommendation, or a forecast of future performance. AssetNext peer scores are recalculated periodically as new data becomes available.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.